Head of Investor Relations
Harmony Biosciences Holdings, Inc. (HRMY)Equibles does not estimate personal net worth.
Get an email with a short summary when Harmony Biosciences Holdings, Inc. publishes a filing, an earnings call transcript or a press release.
Get HRMY alertsBrennan Doyle is recorded as Head of Investor Relations at Harmony Biosciences Holdings, Inc. (HRMY). Brennan Doyle has spoken on 7 earnings calls across 1 company, most recently for Harmony Biosciences Holdings, Inc. on November 4, 2026. Harmony Biosciences Holdings, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Harmony Biosciences Holdings, Inc. includes Jeffrey Dayno (CEO), Jeffrey M. Dayno (CEO and Board Member), Peter Anastasiou (CEO, COO and Board Member) and 7 others.
“Good morning, everyone, and thank you for joining us today as we review Armory Bioscience's third quarter 2026 financial results and provide a business update. Before we start, I encourage everyone to go to the investor section of our website to find the materials that accompany today's discussion.”
“Good morning, everyone, and thank you for joining us today as we review Harmony Bioscience's second quarter 2026 financial results and provide a business update.”
“Good morning, everyone, and thank you for joining us today as we review Harmony Bioscience's first quarter 2026 financial results and provide a business update.”
“Good morning, everyone, and thank you for joining us today as we review Harmony Biosciences Second Quarter 2025 financial results and provide a business update.”
“Good morning, everyone, and thank you for joining us today as we review Harmony Biosciences first quarter 2025 financial results and provide a business update.”
Biotechnology · Healthcare
Head of Investor Relations
